Ignite Creation Date:
2025-12-24 @ 2:59 PM
Ignite Modification Date:
2026-02-26 @ 12:38 AM
Study NCT ID:
NCT01061359
Status:
COMPLETED
Last Update Posted:
2010-12-29
First Post:
2010-02-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast Cancer
Sponsor:
Pfizer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
378-ONC-0030-0144
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Director, Clinical Trial Disclosure Group
Old Organization:
Pfizer, Inc.